New surgical trick could save diabetic feet from amputation

NCT ID NCT07444593

Not yet recruiting Disease control Sponsor: Biodynamik, Inc Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device that moves a small piece of shinbone to improve blood flow and help heal chronic foot ulcers in people with diabetes. One hundred adults with stubborn ulcers that haven't healed after 12 weeks will be enrolled. The goal is to see if this procedure, added to standard wound care, leads to more complete wound healing compared to standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Biodynamik XT3 device and transverse tibial bone transport procedure
What this could lead to: If successful, this could offer a new surgical option to heal stubborn diabetic foot ulcers and reduce the need for leg amputation.
What could go wrong: This is an early study with only 100 people, so results may not apply to everyone. The procedure is surgical and carries risks like infection or poor healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC ULCERS OF THE LOWER LIMB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC ULCERS OF THE LOWER LIMB DIABETIC FOOT ULCER

Contacts and locations

Locations

Mayo Clinic

Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.